Literature DB >> 22134339

Dissecting the HIV-specific immune response: a systems biology approach.

Yoav Peretz1, Cheryl Cameron, Rafick-Pierre Sékaly.   

Abstract

PURPOSE OF REVIEW: Several unique HIV-infected or HIV-resistant cohorts have been studied over the years to try and delineate the correlates of protection. Although several mechanisms have been put forward, studies aiming to integrate the different mechanisms into a comprehensive model are still lacking. Current systems biology approaches emphasize the importance of unifying independent datasets, provide tools that facilitate hypothesis formulation and testing, and direct us toward uncovering novel therapeutic targets by defining molecular networks perturbed during disease. This review will focus on the current findings that utilized systems biology techniques in order to identify correlates of protection from HIV disease progression and resistance to infection in unique cohorts of individuals as well as in nonhuman primate models of SIV infection. RECENT
FINDINGS: Using systems biology technologies and data analysis tools, the studies described herein have found that pathways implicated in survival, cell cycling, inflammation, and oxidative stress work in unison to limit pathology caused by chronic immune activation. This situation favors the survival of effector lymphocytes and limits the dissemination of viral particles in HIV elite controllers, exposed-uninfected individuals, and natural hosts of SIV infection.
SUMMARY: Systems and computational biology tools have clearly expanded our understanding of HIV pathogenesis by unifying independent observations and by giving us novel molecular targets to pursue. These molecular signatures have the potential to uncover correlates of protection in HIV disease and, in the era of personalized medicine, to determine predictive signatures of treatment efficacy and/or failure.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22134339      PMCID: PMC3627479          DOI: 10.1097/COH.0b013e32834ddb0e

Source DB:  PubMed          Journal:  Curr Opin HIV AIDS        ISSN: 1746-630X            Impact factor:   4.283


  39 in total

1.  HIV infection rapidly induces and maintains a substantial suppression of thymocyte proliferation.

Authors:  Marie-Lise Dion; Jean-François Poulin; Rebeka Bordi; Myriam Sylvestre; Rachel Corsini; Nadia Kettaf; Ali Dalloul; Mohamed-Rachid Boulassel; Patrice Debré; Jean-Pierre Routy; Zvi Grossman; Rafick-Pierre Sékaly; Rémi Cheynier
Journal:  Immunity       Date:  2004-12       Impact factor: 31.745

2.  Comparison of HIV-specific CD8 T-cell responses among uninfected individuals exposed to HIV parenterally and mucosally.

Authors:  George Makedonas; Julie Bruneau; Michel Alary; Christos M Tsoukas; Catherine M Lowndes; François Lamothe; Nicole F Bernard
Journal:  AIDS       Date:  2005-02-18       Impact factor: 4.177

3.  Evaluation of the putative role of C-C chemokines as protective factors of HIV-1 infection in seronegative hemophiliacs exposed to contaminated hemoderivatives.

Authors:  J Barretina; J Blanco; A Gutiérrez; L Puig; C Altisent; T Espanol; I Caragol; B Clotet; J A Esté
Journal:  Transfusion       Date:  2000-04       Impact factor: 3.157

4.  Gut mucosal T cell responses and gene expression correlate with protection against disease in long-term HIV-1-infected nonprogressors.

Authors:  Sumathi Sankaran; Moraima Guadalupe; Elizabeth Reay; Michael D George; Jason Flamm; Thomas Prindiville; Satya Dandekar
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-24       Impact factor: 11.205

5.  CD8+ T-lymphocyte activation in HIV-1 disease reflects an aspect of pathogenesis distinct from viral burden and immunodeficiency.

Authors:  Z Liu; W G Cumberland; L E Hultin; A H Kaplan; R Detels; J V Giorgi
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1998-08-01

6.  Human immunodeficiency virus (HIV)-specific cytotoxic T lymphocyte activity in HIV-exposed seronegative persons.

Authors:  N F Bernard; C M Yannakis; J S Lee; C M Tsoukas
Journal:  J Infect Dis       Date:  1999-03       Impact factor: 5.226

7.  Human immunodeficiency virus type 1 (HIV-1)-seronegative injection drug users at risk for HIV exposure have antibodies to HLA class I antigens and T cells specific for HIV envelope.

Authors:  A Beretta; S H Weiss; G Rappocciolo; R Mayur; C De Santis; J Quirinale; A Cosma; P Robbioni; G M Shearer; J A Berzofsky
Journal:  J Infect Dis       Date:  1996-02       Impact factor: 5.226

8.  Elevated elafin/trappin-2 in the female genital tract is associated with protection against HIV acquisition.

Authors:  Shehzad M Iqbal; Terry B Ball; Pauline Levinson; Lillian Maranan; Walter Jaoko; Charles Wachihi; Brian J Pak; Vladimir N Podust; Kristina Broliden; Taha Hirbod; Rupert Kaul; Francis A Plummer
Journal:  AIDS       Date:  2009-08-24       Impact factor: 4.177

9.  Genome-wide analysis of primary CD4+ and CD8+ T cell transcriptomes shows evidence for a network of enriched pathways associated with HIV disease.

Authors:  Jing Qin Wu; Dominic E Dwyer; Wayne B Dyer; Yee Hwa Yang; Bin Wang; Nitin K Saksena
Journal:  Retrovirology       Date:  2011-03-16       Impact factor: 4.602

10.  Lack of infection in HIV-exposed individuals is associated with a strong CD8(+) cell noncytotoxic anti-HIV response.

Authors:  S A Stranford; J Skurnick; D Louria; D Osmond; S Y Chang; J Sninsky; G Ferrari; K Weinhold; C Lindquist; J A Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-02       Impact factor: 11.205

View more
  8 in total

Review 1.  Systems-level analysis of innate immunity.

Authors:  Daniel E Zak; Vincent C Tam; Alan Aderem
Journal:  Annu Rev Immunol       Date:  2014       Impact factor: 28.527

Review 2.  Innate and adaptive anti-HIV immune responses in the female reproductive tract.

Authors:  Marta Rodriguez-Garcia; Mickey V Patel; Charles R Wira
Journal:  J Reprod Immunol       Date:  2013-03       Impact factor: 4.054

Review 3.  Systems biology: personalized medicine for the future?

Authors:  Rui Chen; Michael Snyder
Journal:  Curr Opin Pharmacol       Date:  2012-07-31       Impact factor: 5.547

Review 4.  PD-1 coinhibitory signals: the link between pathogenesis and protection.

Authors:  Deanna A Kulpa; Mariam Lawani; Anthony Cooper; Yoav Peretz; Jeff Ahlers; Rafick-Pierre Sékaly
Journal:  Semin Immunol       Date:  2013-03-31       Impact factor: 11.130

Review 5.  Immunopathogenesis of simian immunodeficiency virus infection in nonhuman primates.

Authors:  Joern E Schmitz; Birgit Korioth-Schmitz
Journal:  Curr Opin HIV AIDS       Date:  2013-07       Impact factor: 4.283

6.  HSP70 binding protein 1 (HspBP1) suppresses HIV-1 replication by inhibiting NF-κB mediated activation of viral gene expression.

Authors:  Priyanka Chaudhary; Sohrab Zafar Khan; Pratima Rawat; Tracy Augustine; Deborah A Raynes; Vince Guerriero; Debashis Mitra
Journal:  Nucleic Acids Res       Date:  2015-11-03       Impact factor: 16.971

7.  Putative roles of purinergic signaling in human immunodeficiency virus-1 infection.

Authors:  Paulo A F Pacheco; Robson X Faria; Leonardo G B Ferreira; Izabel C N P Paixão
Journal:  Biol Direct       Date:  2014-10-29       Impact factor: 4.540

8.  Leucocyte count and C-reactive protein cannot be relied upon in the diagnosis of acute appendicitis in HIV-infected patients.

Authors:  M Truter; V O L Karusseit; D Montwedi; P Becker; T Mokoena
Journal:  BJS Open       Date:  2021-01-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.